Bank Pictet & Cie (Europe)’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,519	Closed	-$284K	–	163
2022 Q1	$284K	Buy	4,519 +443	+11%	+$27.8K	0.01%	146
2021 Q4	$309K	Buy	4,076 +532	+15%	+$40.3K	0.01%	146
2021 Q3	$397K	Sell	3,544 -333	-9%	-$37.3K	0.01%	139
2021 Q2	$628K	Buy	+3,877	New	+$628K	0.02%	125